This educational content is provided by The Peptide Guide for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment
You're likely a reasonable candidate if: You've been symptomatic for more than 12 weeks with confirmed or highly probable prior SARS-CoV-2 infection Standard care has not produced adequate improvement You have a clear symptom cluster that maps to one or more of the mechanisms above You're willing to undergo baseline labs and ongoing clinical monitoring You understand that peptide therapy is an emerging not established intervention for this indication You may need to address other issues first if: Active autoimmune conditions are not yet stabilised You have unmanaged cardiovascular disease You're currently immunosuppressed for another reason You haven't yet tried evidence-based long COVID rehabilitation approaches The most important step is working with a clinician who understands both long COVID pathophysiology and peptide pharmacology not one who simply offers a generic protocol
Rather, other approaches must be considered
Real Peptide Support for Healing, Recovery & Longevity Real Peptide Support for Healing, Recovery & Longevity With consistent use, BPC-157 peptides begin reducing inflammation within the first few days helping ease pressure, stiffness, and discomfort
Most users notice improvement in dark spots and skin tone within 4-6 weeks of consistent use
Some clinics refer to this treatment as a Shiratama IV Drip, while at BIANCA CLINIC offers it under the name High-Dose Glutathione IV Therapy
